Replicability of bulk RNA-Seq differential expression and enrichment analysis results for small cohort sizes.
Where this comes from
- Record sourced from PubMed, PMID 40324149.
- Also identified by DOI 10.1371/journal.pcbi.1011630 and PMC identifier 12077797.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The high-dimensional and heterogeneous nature of transcriptomics data from RNA sequencing (RNA-Seq) experiments poses a challenge to routine downstream analysis steps, such as differential expression analysis and enrichment analysis. Additionally, due to practical and financial constraints, RNA-Seq experiments are often limited to a small number of biological replicates. In light of recent studies on the low replicability of preclinical cancer research, it is essential to understand how the combination of population heterogeneity and underpowered cohort sizes affects the replicability of RNA-Seq research. Using 18'000 subsampled RNA-Seq experiments based on real gene expression data from 18 different data sets, we find that differential expression and enrichment analysis results from underpowered experiments are unlikely to replicate well. However, low replicability does not necessarily imply low precision of results, as data sets exhibit a wide range of possible outcomes. In fact, 10 out of 18 data sets achieve high median precision despite low recall and replicability for cohorts with more than five replicates. To assist researchers constrained by small cohort sizes in estimating the expected performance regime of their data sets, we provide a simple bootstrapping procedure that correlates strongly with the observed replicability and precision metrics. We conclude with practical recommendations to alleviate problems with underpowered RNA-Seq studies.
Medical subject headings
- RNA-Seq
- Gene Expression Profiling
- Sequence Analysis, RNA